Exact Mass: 565.3224

Exact Mass Matches: 565.3224

Found 29 metabolites which its exact mass value is equals to given mass value 565.3224, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Antibiotic FR 900848

C32H43N3O6 (565.3152)

Tyr Leu Thr Arg

C26H43N7O7 (565.3224)

Lys Lys Gln Tyr

(2S)-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2,6-diaminohexanamido]hexanamido]-4-carbamoylbutanamido]-3-(4-hydroxyphenyl)propanoic acid

C26H43N7O7 (565.3224)

Lys Lys Tyr Gln

(2S)-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2,6-diaminohexanamido]hexanamido]-3-(4-hydroxyphenyl)propanamido]-4-carbamoylbutanoic acid

C26H43N7O7 (565.3224)

Lys Gln Lys Tyr

(2S)-2-[(2S)-6-amino-2-[(2S)-4-carbamoyl-2-[(2S)-2,6-diaminohexanamido]butanamido]hexanamido]-3-(4-hydroxyphenyl)propanoic acid

C26H43N7O7 (565.3224)

Lys Gln Tyr Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-4-carbamoyl-2-[(2S)-2,6-diaminohexanamido]butanamido]-3-(4-hydroxyphenyl)propanamido]hexanoic acid

C26H43N7O7 (565.3224)

Lys Tyr Lys Gln

(2S)-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-3-(4-hydroxyphenyl)propanamido]hexanamido]-4-carbamoylbutanoic acid

C26H43N7O7 (565.3224)

Lys Tyr Gln Lys

(2S)-6-amino-2-[(2S)-4-carbamoyl-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-3-(4-hydroxyphenyl)propanamido]butanamido]hexanoic acid

C26H43N7O7 (565.3224)

Gln Lys Lys Tyr

(2S)-2-[(2S)-6-amino-2-[(2S)-6-amino-2-[(2S)-2-amino-4-carbamoylbutanamido]hexanamido]hexanamido]-3-(4-hydroxyphenyl)propanoic acid

C26H43N7O7 (565.3224)

Gln Lys Tyr Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-amino-4-carbamoylbutanamido]hexanamido]-3-(4-hydroxyphenyl)propanamido]hexanoic acid

C26H43N7O7 (565.3224)

Gln Tyr Lys Lys

(2S)-6-amino-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]-3-(4-hydroxyphenyl)propanamido]hexanamido]hexanoic acid

C26H43N7O7 (565.3224)

Tyr Lys Lys Gln

(2S)-2-[(2S)-6-amino-2-[(2S)-6-amino-2-[(2S)-2-amino-3-(4-hydroxyphenyl)propanamido]hexanamido]hexanamido]-4-carbamoylbutanoic acid

C26H43N7O7 (565.3224)

Tyr Lys Gln Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-amino-3-(4-hydroxyphenyl)propanamido]hexanamido]-4-carbamoylbutanamido]hexanoic acid

C26H43N7O7 (565.3224)

Tyr Gln Lys Lys

(2S)-6-amino-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-amino-3-(4-hydroxyphenyl)propanamido]-4-carbamoylbutanamido]hexanamido]hexanoic acid

C26H43N7O7 (565.3224)

Jawsamycin

C32H43N3O6 (565.3152)

A polyketide that is 5-amino-5-deoxy-3,4,5,6-tetrahydrouridine in which one of the hydrogens of the amino group is substituted by a (1E,3E)-1-[(1R,1R,1R,1R,2S,2R,2R,2S)-2-{(E)-2-[(1R,2R)-2-methylcyclopropyl]ethenyl}[1,1:2,1:2,1-quater(cyclopropan)]-2-yl]-5-oxopenta-1,3-dien-5-yl group. It is a metabolite isolated from the bacterium, Streptoverticillium fervens and targets the catalytic subunit of the fungal UDP-glycosyltransferase, the first step in the biosynthesis of glycosylphosphatidylinositol (GPI) anchors. It exhibits broad spectrum antifungal activity against several pathogenic fungi including Mucorales.

4-[[[(2S,3R)-9-[[cyclohexyl(oxo)methyl]amino]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl-methylamino]methyl]benzoic acid

C32H43N3O6 (565.3152)

N-[(5S,6R,9R)-8-[cyclohexyl(oxo)methyl]-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-3-methoxybenzamide

C32H43N3O6 (565.3152)

MRTX-1257 is a selective, irreversible, covalent and orally active KRAS G12C inhibitor, with an IC50 of 900 pM for KRAS dependent ERK phosphorylation in H358 cells[1].

(2e,4e)-n-{[(2r,3s,4r,5r)-3,4-dihydroxy-5-(4-hydroxy-2-oxo-5,6-dihydropyrimidin-1-yl)oxolan-2-yl]methyl}-5-[(1'r,2s)-2'-[(1'r,2r,2's)-2'-[(1e)-2-[(1r,2r)-2-methylcyclopropyl]ethenyl]-[1,1'-bi(cyclopropane)]-2-yl]-[1,1'-bi(cyclopropane)]-2-yl]penta-2,4-dienimidic acid

(2e,4e)-n-{[(2r,3s,4r,5r)-3,4-dihydroxy-5-(4-hydroxy-2-oxo-5,6-dihydropyrimidin-1-yl)oxolan-2-yl]methyl}-5-[(1'r,2s)-2'-[(1'r,2r,2's)-2'-[(1e)-2-[(1r,2r)-2-methylcyclopropyl]ethenyl]-[1,1'-bi(cyclopropane)]-2-yl]-[1,1'-bi(cyclopropane)]-2-yl]penta-2,4-dienimidic acid

C32H43N3O6 (565.3152)

7'-(3,3-dimethyloxirane-2-carbonyl)-1-formyl-2'-hydroxy-1,6-dimethyl-3a-(methylamino)-4,6,7,8,9,9a,10,10a-octahydro-3h-spiro[cyclopenta[b]quinolizine-2,3'-indol]-8-yl butanoate

C32H43N3O6 (565.3152)

(2e,4e)-n-{[(2s,3s,4r,5s)-3,4-dihydroxy-5-(4-hydroxy-2-oxo-5,6-dihydropyrimidin-1-yl)oxolan-2-yl]methyl}-5-[(1s,1's,2r,2's)-2'-[(1s,1's,2s,2'r)-2'-[(1e)-2-[(1r,2r)-2-methylcyclopropyl]ethenyl]-[1,1'-bi(cyclopropane)]-2-yl]-[1,1'-bi(cyclopropane)]-2-yl]penta-2,4-dienimidic acid

(2e,4e)-n-{[(2s,3s,4r,5s)-3,4-dihydroxy-5-(4-hydroxy-2-oxo-5,6-dihydropyrimidin-1-yl)oxolan-2-yl]methyl}-5-[(1s,1's,2r,2's)-2'-[(1s,1's,2s,2'r)-2'-[(1e)-2-[(1r,2r)-2-methylcyclopropyl]ethenyl]-[1,1'-bi(cyclopropane)]-2-yl]-[1,1'-bi(cyclopropane)]-2-yl]penta-2,4-dienimidic acid

C32H43N3O6 (565.3152)

(2e,4e)-n-{[(2s,3r,4r,5r)-3,4-dihydroxy-5-(4-hydroxy-2-oxo-5,6-dihydropyrimidin-1-yl)oxolan-2-yl]methyl}-5-[(1r,1'r,2r,2's)-2'-[(1r,1's,2r,2'r)-2'-[(1z)-2-[(1r,2r)-2-methylcyclopropyl]ethenyl]-[1,1'-bi(cyclopropane)]-2-yl]-[1,1'-bi(cyclopropane)]-2-yl]penta-2,4-dienimidic acid

(2e,4e)-n-{[(2s,3r,4r,5r)-3,4-dihydroxy-5-(4-hydroxy-2-oxo-5,6-dihydropyrimidin-1-yl)oxolan-2-yl]methyl}-5-[(1r,1'r,2r,2's)-2'-[(1r,1's,2r,2'r)-2'-[(1z)-2-[(1r,2r)-2-methylcyclopropyl]ethenyl]-[1,1'-bi(cyclopropane)]-2-yl]-[1,1'-bi(cyclopropane)]-2-yl]penta-2,4-dienimidic acid

C32H43N3O6 (565.3152)

[(2s,4s,6s)-6-[(1e,3e)-5-[(2s,3s,5r,6r)-5-{[(2z,4s)-4-(acetyloxy)-1-hydroxypent-2-en-1-ylidene]amino}-3,6-dimethyloxan-2-yl]-3-methylpenta-1,3-dien-1-yl]-4-(ethoxymethyl)-4-hydroxyoxan-2-yl]acetic acid

[(2s,4s,6s)-6-[(1e,3e)-5-[(2s,3s,5r,6r)-5-{[(2z,4s)-4-(acetyloxy)-1-hydroxypent-2-en-1-ylidene]amino}-3,6-dimethyloxan-2-yl]-3-methylpenta-1,3-dien-1-yl]-4-(ethoxymethyl)-4-hydroxyoxan-2-yl]acetic acid

C30H47NO9 (565.3251)

(1r,2r,3as,6s,8r,9as,10ar)-7'-[(2s)-3,3-dimethyloxirane-2-carbonyl]-1-formyl-2'-hydroxy-1,6-dimethyl-3a-(methylamino)-4,6,7,8,9,9a,10,10a-octahydro-3h-spiro[cyclopenta[b]quinolizine-2,3'-indol]-8-yl butanoate

(1r,2r,3as,6s,8r,9as,10ar)-7'-[(2s)-3,3-dimethyloxirane-2-carbonyl]-1-formyl-2'-hydroxy-1,6-dimethyl-3a-(methylamino)-4,6,7,8,9,9a,10,10a-octahydro-3h-spiro[cyclopenta[b]quinolizine-2,3'-indol]-8-yl butanoate

C32H43N3O6 (565.3152)

{6-[5-(5-{[4-(acetyloxy)-1-hydroxypent-2-en-1-ylidene]amino}-3,6-dimethyloxan-2-yl)-3-methylpenta-1,3-dien-1-yl]-4-(ethoxymethyl)-4-hydroxyoxan-2-yl}acetic acid

C30H47NO9 (565.3251)